Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence.

Categories:
Posted on

Link to article at PubMed

Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence.

Eur Heart J. 2020 Apr 23;:

Authors: Kuster GM, Osswald S

PMID: 32324223 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *